Phenylephrine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), Rx Only, 5 mL Vial, Manufacture...

FDA Recall #D-0402-2023 — Class II — February 7, 2023

Recall #D-0402-2023 Date: February 7, 2023 Classification: Class II Status: Terminated

Product Description

Phenylephrine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), Rx Only, 5 mL Vial, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA; Vial NDC 16729-465-31, UPC 3 16729 46531 1; Carton NDC 16729-465-03, UPC 3 16729 46503 8

Reason for Recall

CGMP Deviations: recalling drug products following an FDA inspection.

Recalling Firm

Accord Healthcare, Inc. — Durham, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

5,090 vials

Distribution

United States including Puerto Rico and Canada

Code Information

Batches: R2101570, R2101574, R2101576, Exp. Date 11/30/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated